RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business... Show more
RXO stock has navigated volatile trading in recent weeks, reflecting broader freight sector pressures from softening truckload demand and capacity shifts. Shares experienced sharp declines following Q3 earnings, which highlighted margin compression despite revenue growth, but have shown partial recovery amid cost-saving announcements. The asset-light brokerage model continues to benefit from strong less-than-truckload and last-mile momentum, offsetting full-truckload weakness. Trading near the lower end of its 52-week range with elevated beta, RXO remains sensitive to industry cycles, with investor focus on Q4 guidance and early 2026 recovery signals.
RXO's stock has faced downward pressure in recent trading sessions, primarily triggered by its November 6, 2025, Q3 earnings release, which revealed adjusted EPS of $0.01—far below the expected $0.25—prompting a pre-market drop of over 12%. Revenue climbed to $1.4 billion from $1.0 billion year-over-year, fueled by brokerage volume up 1%, with less-than-truckload surging 43% to comprise a larger mix, though full-truckload fell 11% amid persistent demand softness. Brokerage gross margins slipped to 13.5%, reflecting higher purchased transportation costs and tightening capacity seen late in the quarter.
Q4 guidance intensified selling, forecasting adjusted EBITDA of $20-30 million, brokerage gross margins of 12-13%, and low-single-digit volume declines, as truckload market tightness—driven by carrier exits and regulatory scrutiny on drivers—pressures profitability without demand rebound. Management highlighted new cost initiatives targeting over $30 million in annualized savings through productivity gains and restructuring, partially mitigating headwinds.
Analyst reactions were mixed: Truist lowered its price target to $18 from $20 on January 15, 2026, citing margin risks but retaining Buy; Benchmark held Neutral amid brokerage pressures; Wolfe upgraded to Peer Perform post-55% YTD decline; Morgan Stanley shifted to Overweight at $19, viewing the selloff as a valuation opportunity. Consensus remains Hold, with targets averaging $16.
Positive offsets include Coyote Logistics integration ahead of schedule since its September 2024 close, boosting scale to third-largest U.S. broker with expanded carrier network and synergies exceeding expectations. Last Mile delivery posted 12% stop growth, and Managed Transportation grew its pipeline. Macro factors like decelerating spot rates (1.8% YoY in Q3) and fragile capacity add volatility, but potential Fed cuts could aid manufacturing freight. Overall, price action links directly to freight cycle woes, tempered by operational resilience.
As RXO enters 2026, attention centers on truckload market recovery amid ongoing capacity rationalization, including declining Class 8 orders and stricter driver regulations that could tighten supply further. Analysts project FY2026 EPS at $0.12, up from FY2025's -$0.01, assuming demand inflection and cost synergies realization. Full Coyote integration promises enhanced network density, diversified verticals, and at least $50 million in annualized synergies, bolstering scale advantages.
Investors should track LTL and Last Mile momentum, which have shown resilience with double-digit growth, alongside brokerage margin expansion from $30+ million cost savings and AI-driven tools like spot quoting. Risks include prolonged freight softness, trade policy shifts, and macroeconomic drags on manufacturing PMI. Opportunities lie in potential rate normalization if capacity exits persist and interest rate cuts spur volumes. Competitive positioning via RXO Connect platform and $2 billion Managed Transportation pipeline will be pivotal for capturing share in a cyclical rebound.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RXO advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 01, 2026. You may want to consider a long position or call options on RXO as a result. In of 56 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
RXO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 173 cases where RXO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for RXO moved out of overbought territory on June 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where RXO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for RXO turned negative on June 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RXO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.822) is normal, around the industry mean (3.446). RXO's P/E Ratio (670.667) is considerably higher than the industry average of (159.689). RXO's Projected Growth (PEG Ratio) (172.133) is slightly higher than the industry average of (36.064). RXO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.011). P/S Ratio (0.760) is also within normal values, averaging (2.006).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Trucking